So it doesn't take very much, I think, to have buy-in once you really explain it on that level, uh, that this c- can, is not only good for the condition and the patient, but also in the day-to-day runnings efficiencies of the practice.

practice.You know, I think both of you had such great points, and I wanna, um, address one thing that you, you said, Christine, and that is the perceived barrier from the doctor, staff, and community referral base.

And I say perceived because we think that we're going to have a hard time convincing all of these people that this is the right thing.

And in truth, the community doctors love this 'cause they really don't love treating glaucoma, they don't love doing prior auths for drops.

They don't love a lot about the uncertainty of what's happening with their patients.

And once I educated my community doctors, we ho- we held dinners and talks, and I opened myself up to virtual consultations for patients, the floodgates opened.

We've never been busier than we are right now because they're sending us these patients early, we're managing them.

And then that barrier suddenly s- kind of slips away, right? You're gonna talk a little bit about whatever you want to do, but half the time I'll walk in and they'll be like, "Oh yeah, I already heard about, you know, that, that stent you're going to put into the eye."